Brevibloc

Category: Drug Studies for the Heart

Start Date: 06/07/2012

Evaluates the hemodynamic outcomes with Brevibloc premixed injection (esmolol hydrochloride) in patients with supraventricular tachycardia/atrial fibrillation in medical and neurological intensive care units in the United States.

Principal Investigator: Gopinath Upamaka, MD, FACC

Contact the research coordinator: Tamithy Huber